Cargando…
The prognostic impact of bone metastasis in patients with metastatic urothelial carcinoma treated with first-line platinum-based chemotherapy
BACKGROUND: In metastatic urothelial cancer (mUC), bone metastasis (BM) are associated with significant morbidity and mortality, yet their role as an independent prognostic variable remains unclear. We aimed to determine the impact of BM on overall survival (OS) in patients with mUC treated with fir...
Autores principales: | Alqaisi, Husam A., Stecca, Carlos, Veitch, Zachary W., Riromar, Jamila, Kaiser, Jeenan, Fallah-Rad, Nazanin, Jiang, Di Maria, North, Scott, Samnani, Sunil, Alimohamed, Nimira, Sridhar, Srikala S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066632/ https://www.ncbi.nlm.nih.gov/pubmed/35520101 http://dx.doi.org/10.1177/17588359221094879 |
Ejemplares similares
-
The Rapidly Evolving Landscape of First‐Line Targeted Therapy in Metastatic Urothelial Cancer: A Systematic Review
por: Lavoie, Jean‐Michel, et al.
Publicado: (2021) -
Metastatic Urothelial Cancer: a rapidly changing treatment landscape
por: Stecca, Carlos, et al.
Publicado: (2021) -
Improving adherence and health outcomes in testicular cancer
survivors using a mobile health-based intervention: A mixed-methods pilot
study
por: Deleemans, Julie M, et al.
Publicado: (2023) -
The Prognostic Role of the Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer: A Retrospective, Multi-Institutional Study
por: Kaiser, Jeenan, et al.
Publicado: (2018) -
Kidney and Cancer Outcomes with Standard Versus Alternative Chemotherapy Regimens for First-Line Treatment of Metastatic Urothelial Carcinoma
por: Côté, Gabrielle, et al.
Publicado: (2023)